|
Sep 08, 2020
|
Nkarta Announces September 2020 Virtual Investor Conference Schedule
|
|
|
Aug 20, 2020
|
Nkarta Reports Second Quarter 2020 Financial Results
|
|
|
Jul 14, 2020
|
Nkarta Announces Closing of Upsized Initial Public Offering and Exercise in Full of Underwriters' Option to Purchase Additional Shares
|
|
|
Jul 10, 2020
|
Nkarta Announces Pricing of Initial Public Offering
|
|
|
Jun 22, 2020
|
Nkarta Therapeutics Presents Preclinical Findings Supporting Gene Editing of Natural Killer Cells and the Combination of Engineered NK plus T Cells at the American Association for Cancer Research (AACR) Virtual 2020 Annual Meeting II
|
|
|
Apr 27, 2020
|
Nkarta Therapeutics Appoints Two New Independent Directors
|
|
|
Jan 09, 2020
|
Nkarta Therapeutics to Present at the J.P. Morgan Healthcare Conference
|
|
